Leaflet: Information for the user
Topionic 100 mg/ml cutaneous solution
Povidone iodine
Read this leaflet carefully before starting to use this medicine, as it contains important information for you. Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor, pharmacist, or nurse.
|
Contents of the leaflet:
Topionic is a cutaneous antiseptic medicine. The active ingredient, povidone iodine, belongs to the group of drugs called iodine products.
Topionic is used as a general skin antiseptic for small wounds and superficial cuts, minor burns, or abrasions.
Do not use Topionic
Warnings and precautions
Consult your doctor, pharmacist, or nurse before using Topionic cutaneous solution.
Interactions with diagnostic tests
This medicine may interfere with the results of diagnostic tests for thyroid function and may lead to errors in test results with toluidine or guaiacol for the determination of hemoglobin or glucose in feces or urine, so you should inform your doctor before undergoing these tests.
Inform your doctor when you need to undergo any type of diagnostic test.
Children
Other medicines and Topionic
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
Topionic should not be applied at the same time as other products that contain mercury derivatives, silver, hydrogen peroxide, or taurolidine (antiseptics), as they react with iodine to form compounds that are irritants.
If you are taking lithium (a medicine used to treat some types of depression), you should avoid continuous use of Topionic without first consulting your doctor.
When used at the same time or after antiseptics with octenidine, a transient dark discoloration of the involved areas may appear.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Use only if strictly indicated, and its use should be kept to a minimum. Avoid continuous use.
Its use could produce transient hypothyroidism in fetuses and newborns. Thyroid control may be necessary in children.
Driving and using machines
No effects on the ability to drive or use machines have been described.
Topionic contains hydrogenated polyoxyethylene castor oil
This medicine may cause skin reactions because it contains hydrogenated polyoxyethylene castor oil.
This medicine contains niauli essence and eucalyptus essential oil, which contain d-limonene. D-limonene may cause allergic reactions. The terpene derivatives of this excipient may decrease the epileptogenic threshold and lead to neurological accidents such as convulsions in infants and children in excessive doses.
Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor. In case of doubt, ask your doctor or pharmacist.
Topionic is a solution for cutaneous use.
After washing and drying, apply a small amount directly to the affected area 2 to 3 times a day.
Use in children
The use in children under 30 months, if indispensable, will be limited to a brief and not extensive application, followed by a rinse with sterile water.
If you use more Topionic than you should
In case you apply an excessive amount of product and skin irritation occurs, wash the affected area with plenty of water, and if irritation continues, consult your doctor.
The symptoms could be abdominal pain, anuria (suppression or reduction of urine), circulatory, respiratory, and metabolic problems. Excess iodine can produce goiter, hypothyroidism, and hyperthyroidism.
In case of accidental ingestion, go to a medical center or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you have any other doubts about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Although povidone iodine is less irritating than iodine, local skin reactions, such as local irritation, itching, or burning, can rarely occur. In these cases, treatment should be discontinued, and the affected area should be washed with water.
Rare side effects (may affect between 1 and 10 in 10,000 people) are hypersensitivity and contact dermatitis, which manifests with red skin, small blisters, and itching.
Very rare side effects (may affect less than 1 in 10,000 people) include anaphylactic reactions (severe allergic reaction), hyperthyroidism with tachycardia and agitation, and angioedema (swelling caused by allergy).
Other side effects of unknown frequency have been hypothyroidism, electrolyte imbalance, metabolic acidosis, acute kidney failure, liver failure, abnormal blood osmolality, exfoliative dermatitis, dry skin, and chemical burns on the skin.
If you consider that any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a cool place.
Do not use this medicine after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition ofTopionic
Appearance of the product and package contents
The solution is dark brown in color. It is presented in 25 ml, 100 ml, and 500 ml polypropylene bottles.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Esteve Pharmaceuticals, S.A.
Passeig de la Zona Franca, 109
08038 Barcelona (Spain)
Manufacturer:
Reig Jofré, S.A.
C/ Gran Capità, 10
08970 Sant Joan Despí
Barcelona (Spain)